Brooks Laboratories Limited (NSEI: BROOKS)
Health Care · Life Sciences Tools & Services · IN
Rs70.13
+27.97% today · -45.3% 1Y
Brooks Laboratories Limited (NSEI: BROOKS) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $21.35M and employs 347 people.
Over the last twelve months the share price has lost 45.3%, trading between 36.30 and 131.56.
Tweenvest scores Brooks Laboratories Limited across four factors: quality 73/100, value 46/100, growth 15/100. Its strongest factor is quality.
BROOKS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $21.35M
- Revenue (TTM)
- $8.80M
- P/E
- 15.61
- EPS
- 4.49
- Dividend yield
- —
- Beta (5Y)
- 1.15
- 52-week high
- Rs131.56
- 52-week low
- Rs36.30
- Avg volume (3M)
- —
- Shares outstanding
- 29.46M
- Employees
- 347
- Next earnings
- —
About Brooks Laboratories Limited
Brooks Laboratories Limited is a pharmaceutical enterprise engaged in the contractual manufacturing and distribution of medicinal products. The company serves both the Indian domestic market and international clients. Its comprehensive product portfolio includes carbapenem medications, various tablets, dry syrups, both liquid and powdered injectable solutions, and specialized eye and ear drops. Brooks Laboratories Limited was established in 2002 and is headquartered in Mumbai, India.
- ISIN
- INE650L01011
- Founded
- 2002
- Listed since
- Sep 5, 2011
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| DT&CRO CO., Ltd.KOSDAQ: A383930 | $23.44M | ₩2,465.00 | +24.94% |
| BioLASCO Taiwan Co., Ltd.TPEX: 6662 | $22.96M | NT$28.50 | -0.35% |
| IXICO plcAIM: IXI | $22.46M | £0.08 | +3.33% |
| HyEnergy S.A.WSE: HEN | $21.40M | zł— | — |
| Human Metabolome Technologies, Inc.TSE: 6090 | $21.22M | ¥604.00 | -0.33% |
| atect corporationTSE: 4241 | $20.21M | ¥724.00 | +1.54% |
| C&R Research Inc.KOSDAQ: A359090 | $19.88M | ₩2,325.00 | +1.97% |
| SLS BIO Co., LtdKOSDAQ: A246250 | $19.85M | ₩— | — |
Figures last refreshed Oct 11, 2026.